3B BlackBio Dx Limited submitted a regulatory disclosure to BSE Limited regarding an investor meeting conducted under SEBI Listing Obligations and Disclosure Requirements Regulation 30.
The company held a one-to-one meeting with Param Capital, Mumbai on Saturday, August 29, 2026, from 13:00 hrs to 14:00 hrs India Time (duration: 60 minutes). This meeting was a continuation of previous communications referenced under Ref. No.P-66/2026-27/29 dated August 25, 2026.
During the meeting, the company specifically discussed information that was already available in the public domain and confirmed that no unpublished price sensitive information (UPSI) pertaining to the company was shared with the investor.
The company reiterated information previously shared through its Q1-FY27 Investor Presentation, which was earlier intimated to the Stock Exchanges via Ref. No.P66/2026-27/27 dated August 13, 2026. The presentation covered financial results for the quarter ended June 30, 2026.
The disclosure includes a web link to the investor presentation: https://www.kilpest.com/upload/Investor's%20Presentation%20August%202026.pdf
The communication was digitally signed by Nikhil Kuber Dubey, Whole Time Director (DIN: 00538049), on August 29, 2026 at 14:32:30 IST.
Financial Impact
No financial impact disclosed. The meeting was informational only, discussing previously published materials.